WHO panel advises against Gilead’s remdesivir for patients hospitalized with Covid-19 ...News

Russia Today - News
WHO panel advises against Gilead’s remdesivir for patients hospitalized with Covid-19
A World Health Organization panel said on Friday there is no evidence Gilead’s remdesivir improves survival or reduces the need for ventilation and did not recommend the drug for all patients hospitalized with Covid-19. The WHO’s Guideline Development Group (GDG) issued the guideline citing “a lack of evidence that remdesivir improved outcomes that matter to patients such as reduced mortality, need for mechanical ventilation, time to clinical improvement,” among other things. The drug, called Veklury, or remdesivir, was seen as a potentially effective treatment for the coronavirus in the summer after early trials, and was even used to

Hence then, the article about who panel advises against gilead s remdesivir for patients hospitalized with covid 19 was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WHO panel advises against Gilead’s remdesivir for patients hospitalized with Covid-19 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News